The FDA has issued a new draft guidance on the use of power morcellators linked to the spread of undiagnosed cancers, indicating they should only be used with adequate containment…
A new study finds that women with uterine sarcoma who undergo morcellation face a significantly higher risk of death.
Power morcellators used during a laparoscopic hysterectomy or uterine fibroid surgery may cause the spread of aggressive cancer.
The CDC is considering a review of how gynecologists evaluate women for hidden uterine cancer and other sarcomas, which may result in new guidelines.
The FDA reports that risks of contracting uterine cancer from power morcellation could be as high as 1-in-225, and also warns that cancer spread through morcellation appears to be more…
A new editorial say failures to more quickly identify and react to power morcellator cancer risk were in part due to a lack of a sound post-marketing surveillance system to…
A long-ignored technique known as embolization may be an under-used means of uterine fibroid removal, according to a new study. which comes as the medical community abandons morcellation procedures due…
A GAO report indicates that the FDA's adverse reporting system and its voluntary nature may have delayed the agency from detecting heightened cancer risks linked to the use of power…
A public workshop is being held today by the FDA to discuss improving reporting by hospitals on potentially dangerous medical devices after a number of incidents where hospitals knew devices…
A new study warns that women over 50 may be more vulnerable to leiomyosarcoma cancer risks linked to the use of power morcellators.
